Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 16.50
-1.00 (-5.71%)
At close: Mar 12, 2026
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 363.28 million as of March 12, 2026. Its market cap has increased by 76.37% in one year.
Market Cap
363.28M
Enterprise Value
372.04M
Revenue
55.93M
Ranking
n/a
PE Ratio
15.74
Stock Price
16.50
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 363.28M, an increase of 17.55%. That is a compound annual growth rate of 0.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 363.28M | -23.69% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 910.45M |
| Basilea Pharmaceutica AG | 649.00M |
| Santhera Pharmaceuticals Holding AG | 221.43M |
| Molecular Partners AG | 136.69M |
| BioVersys AG | 133.33M |
| Xlife Sciences AG | 121.70M |
| EvoNext Holdings | 6.27M |
| Addex Therapeutics | 5.25M |